Slide 1 of 5
AmbryHomepageHero1
shape-element-one
shape-element-two

Industry-leading genetic testing in hereditary cancer 
and rare disease

For over 25 years our high-quality, accessible genetic testing solutions have shaped important care decisions that patients and families make with their healthcare providers.

Webinars_Hero
shape-element-one
shape-element-two
EducateNext

Consent Considerations in Clinical and Research Genomics

Starting Wednesday, August 5th 10:00 AM PDT

Multi-racial group of scientists researching and teamworking in laboratory
shape-element-one
shape-element-two

We’ve Upgraded Your Learning Experience.

Access on-demand webinars on our newly launched medical educational platform.

Close-up Of A Person’s Hand Using Digital Tablet
shape-element-one
shape-element-two

Genetics in Medicine Study Shows Ambry’s ExomeReveal® RNA Testing Improves Diagnostic Clarity in Exome Testing.

Research highlights how ExomeReveal RNA analysis resolves ambiguity around uncertain variants.

MedTech2026_BannerImage_1900x500_flip
shape-element-one
shape-element-two

Ambry Genetics’ CARE Program® Named 2026 MedTech Breakthrough Winner

Among more than 5,000 global nominations, CARE was recognized for excellence in digital health and medical technology.

Trusted Expertise. Meaningful Progress.

Driven by scientific rigor, thoughtful innovation, and a history of collaboration.
400
+
Publications
1.8
Million +
Variants to ClinVar
1
Million +
RNA tests conducted

Why We’re Different

source_99cd080e65a4a97ecf5ef7fc7a8b92b6f36d7097

Built to Find Answers

Helping patients and providers navigate healthcare decisions with confidence.
Classifi_Homepage

Classifi

How Ambry transforms raw genetic data into actionable clinical insights.
The kitchen is our favourite place to be. Shot of a multigenerational family baking together in the kitchen.

Patient for Life

Our promise to patients living with rare and undiagnosed conditions, today and in the future.

“I know for certain that an entire team of people is continuing to research for me. And once an answer is found, I know that our doctors are going to be notified. We don’t have to do another blood draw. We don’t have to pay any more money out of pocket. We’re just going to get the answers.”

Michelle Majewski
Parent, Ambry Patient for Life participant

“Ambiguity in genetic test results is challenging for health care providers and for our patients. The fact that supplemental RNA testing has the potential to offer clarity for an additional 1 in 50 patients is a game changer. Ambry Genetics is setting a new bar for genetic testing.”

Meagan Farmer, MS, MBA, LCGC
Genetic Counselor, formerly of University of Alabama at Birmingham

“The validation of CARE’s accuracy reinforces what we’ve experienced. With demonstrated 99.5% accuracy in applying clinical guidelines, we can confidently scale hereditary cancer risk assessment across our community hospitals, ensuring more patients have access to potentially life-saving genetic insights.”

Dax Kurbegov, MD
Senior Vice President, HCA Healthcare, Sarah Cannon Cancer Network

“They say, ‘knowledge is power,’ and I feel that my knowledge of being a BRCA1 carrier has empowered me to make health decisions that will allow me to impact my family and my community for decades to come.”

Ben Huebsch
Middle School Principal, Patient Advocate
Slide 1 of 0